EMA — authorised 27 June 2006
- Status: approved
EMA authorised Tysabri on 27 June 2006
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 27 June 2006.
Biogen Idec is the originator. The local marketing authorisation holder may differ — check the official source linked above.